These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19390864)

  • 21. The Tay-Sachs disease screening program in the U.S. as a model for the control of genetic disease: an historical view.
    Edelson PJ
    Health Matrix Clevel; 1997; 7(1):125-33. PubMed ID: 10167171
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening for genetic diseases.
    Motulsky AG
    N Engl J Med; 1997 May; 336(18):1314-6. PubMed ID: 9113938
    [No Abstract]   [Full Text] [Related]  

  • 23. [Large-scale population-based genetic screening and prenatal diagnosis for thalassemias in Zhuhai City of Guangdong Province].
    Zhou YQ; Shang X; Yin BM; Xiong F; Xiao QZ; Zhou WJ; Zhang YL; Xu XM
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):90-5. PubMed ID: 22455738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model.
    Kaback MM
    Eur J Pediatr; 2000 Dec; 159 Suppl 3():S192-5. PubMed ID: 11216898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based carrier screening and prenatal diagnosis.
    Strom CM
    MLO Med Lab Obs; 2004 Aug; 36(8):12-7; quiz 20-1. PubMed ID: 15366363
    [No Abstract]   [Full Text] [Related]  

  • 26. Pre-marriage prevention of thalassaemia: report of a 100,000 case experience in Isfahan.
    Ghanei M; Adibi P; Movahedi M; Khami MA; Ghasemi RL; Azarm T; Zolfaghari B; Jamshidi HR; Sadri R
    Public Health; 1997 May; 111(3):153-6. PubMed ID: 9175458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a Tay-Sachs disease screening program.
    Gason AA; Sheffield E; Bankier A; Aitken MA; Metcalfe S; Barlow Stewart K; Delatycki MB
    Clin Genet; 2003 May; 63(5):386-92. PubMed ID: 12752571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.
    Lew RM; Burnett L; Proos AL; Barlow-Stewart K; Delatycki MB; Bankier A; Aizenberg H; Field MJ; Berman Y; Fleischer R; Fietz M
    J Paediatr Child Health; 2015 Mar; 51(3):271-9. PubMed ID: 24923490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.
    Zuckerman S; Lahad A; Shmueli A; Zimran A; Peleg L; Orr-Urtreger A; Levy-Lahad E; Sagi M
    JAMA; 2007 Sep; 298(11):1281-90. PubMed ID: 17878420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Committee Opinion No. 691: Carrier Screening for Genetic Conditions.
    Obstet Gynecol; 2017 Mar; 129(3):e41-e55. PubMed ID: 28225426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ovrselling of genetic anxiety.
    Goodman MJ; Goodman LE
    Hastings Cent Rep; 1982 Oct; 12(5):20-7. PubMed ID: 7174291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variables that underlie cost efficacy of prenatal screening.
    Kinzler WL; Morrell K; Vintzileos AM
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):277-86, v-vi. PubMed ID: 12108828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tay-Sachs disease carrier screening: a model for prevention of genetic disease.
    Kaplan F
    Genet Test; 1998; 2(4):271-92. PubMed ID: 10464605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools.
    Ioannou L; Massie J; Lewis S; Petrou V; Gason A; Metcalfe S; Aitken MA; Bankier A; Delatycki MB
    Clin Genet; 2010 Jul; 78(1):21-31. PubMed ID: 20597919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carrier screening panels for Ashkenazi Jews: is more better?
    Leib JR; Gollust SE; Hull SC; Wilfond BS
    Genet Med; 2005 Mar; 7(3):185-90. PubMed ID: 15775754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carrier screening for beta-thalassemia during pregnancy in India: a 7-year evaluation.
    Colah R; Surve R; Wadia M; Solanki P; Mayekar P; Thomas M; Gorakshakar A; Dastur A; Mohanty D
    Genet Test; 2008 Jun; 12(2):181-5. PubMed ID: 18439108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of utilization of Tay-Sachs screening.
    Garber AP; Platt LD; Wang SJ; Jam K; Carlson DE; Rotter JI
    Obstet Gynecol; 1993 Sep; 82(3):460-3. PubMed ID: 8355954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic screening: marvel or menace?
    Rowley PT
    Science; 1984 Jul; 225(4658):138-44. PubMed ID: 6729472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "I'm Healthy, It's Not Going To Be Me": Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia.
    Beard CA; Amor DJ; Di Pietro L; Archibald AD
    Am J Med Genet A; 2016 Aug; 170(8):2052-9. PubMed ID: 27150953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heredity insurance.
    Pines M
    N Y Times Mag; 1978 p 78+; 30 Apr 1978():. PubMed ID: 11663045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.